Investigation of Phospholipids in Ethanol Affected Prenatal Mouse Brain Using DESI-MS Imaging by Bagga, Aafreen Kaur
 
 
 
 
 
INVESTIGATION OF PHOSPHOLIPIDS IN 
ETHANOL AFFECTED PRENATAL MOUSE 
BRAIN USING DESI-MS IMAGING 
 
 
 
 
     Aafreen Kaur Bagga 
 
 
 
 
 
 
A THESIS SUBMITTED TO  
THE FACULTY OF GRADUATE STUDIES 
IN PARTIAL FULFILLMENT OF THE REQUIREMENTS 
FOR THE DEGREE OF 
MASTER OF SCIENCE 
 
 
 
 
GRADUATE PROGRAM IN CHEMISTRY 
YORK UNIVERSITY 
TORONTO, ONTARIO 
 
 
 
                December 2018 
 
 
      
        © Aafreen Kaur Bagga, 2018 
ii 
 
Abstract 
 
The prevalence of fetal alcohol spectrum disorder (FASD) is increasing exponentially due 
to the incognizant consumption of alcohol during early pregnancy. This research primarily 
focuses on monitoring the variation of phospholipid distribution in various regions of the brain 
using DESI-MS imaging. FASD mouse models were used in this study in which alcohol was 
administered to the pregnant mice during first trimester and 30 day old offsprings were chosen 
for the analysis. Principal component analysis was performed on six samples that illustrated 
enhanced level of PC(16:0/16:0), PC (16:0/18:1) throughout the brain; while the level of PE(P-
16:0/22:6), PS(18:0/18:1), PS(18:0/20:0), PS(18:0/22:6), PI(18:0/20:4) and ST(24:1) increased 
specifically in the white matter of the brain in response to alcohol consumption. Conversely, 
alcohol reduced the level of PC(16:0/18:1), PE(P-18:0/22:6) and PC(18:0/18:1) exclusively in 
white matter of the brain. The changes noted in various phospholipids lay strong foundation for 
understanding alcohol mediated biochemistry in fetal brain development.  
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CHAPTER I 
Introduction 
 
1.1. Fetal Alcohol Spectrum Disorder 
 
Fetal Alcohol Spectrum Disorder (FASD) is a broad term for diseases that encompass 
psychological, behavioral and neurobiological deficits resulting from alcohol consumption 
during pregnancy. FASD is most prevalent in South-African communities with 135-207 FASD 
cases per 1,000 births while the prevalence rate varies from 2.3% to 6.3% of the newly born 
children in developed countries.1 The extent of fetal damage due to ethanol exposure depends 
on couple of factors including the timing, dose and frequency of ethanol consumed.2 The 
impact of environmental agents on brain development is as critical as the genetic factors since 
constituents of vittles consumed by expectant mother can be transported to fetus.3 Alcohol is 
one of the environmental agents that has been shown to cause significant growth deficits in the 
fetus. It can result in facial dysmorphology and can also hinder the growth of central nervous 
system (CNS). Children afflicted by FASD are likely to have short palpebral fissures, smooth 
philtrum and thin upper lip.4,5 FASD can also result in reduced brain size and volume.6 MRI 
studies have demonstrated underdevelopment of specific brain areas such as hippocampus, 
cerebellum, basal ganglia, caudate nucleus, frontal lobe, and corpus callosum which causes 
impairment in learning, reading, memory, coordination, and psychological functioning.6,7 On the 
other hand, cortex has been found to be greater in thickness with atypical patterns of pruning 
and myelination that may obstruct neural connections.6,8 
 
 
1.1.1. Ethanol migration to the fetus 
 
Ethanol consumed by the expectant women can directly impact the developing fetus as 
ethanol, being small uncharged polar molecule, has the ability to rapidly diffuse through lipid 
membrane and merge into fetal blood through placenta.9 Ethanol can also cross the blood brain 
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barrier (BBB) and impair the growth of neurons along with disrupting critical signaling pathways 
essential for brain maturation. Furthermore, presence of ethanol in placenta prompts umbilical 
cord to vasoconstrict in an attempt to reduce the transport of ethanol to the fetus. However, 
vasoconstriction also reduces the migration of oxygen and other essential nutrients to the fetus 
that in turn effects the development of CNS.10,11 Once ethanol enters the fetal blood stream, it 
can be metabolized by numerous enzymes through oxidative and non-oxidative pathways. 
 
1.1.2. Ethanol metabolism 
 
In mammals, metabolism of ethanol via oxidative pathway includes alcohol 
dehydrogenase (ADH) and cytochrome P450 2E1 (CYP2E1) enzymes that transform ethanol to 
acetaldehyde followed by aldehyde dehydrogenase (ALDH) that catalyzes acetaldehyde to 
acetate in mitochondria (Figure 1). Previous studies have demonstrated the presence of both 
ADH and ALDH in the fetus while activity of these enzymes have been shown to be significantly 
low in comparison to the adult.10,12 Consequently, ethanol metabolic intermediates accumulate 
in the fetal body and impair neuronal survival and proliferation, mitochondrial function, ATP 
production, membrane integrity and neurotransmitter function.13 
 
Acetaldehyde accumulates in the body when rate of ethanol consumption is greater 
than the rate of ethanol metabolism as well as when ethanol metabolic pathway slows down in 
the case of genetic variations persisting in ALDH2.10,13 Acetaldehyde, being electrophilic in 
nature, reacts rapidly with lipids, proteins and DNA; thereby impairing lipid and protein 
function, as well as promoting DNA damage.13 Acetaldehyde can alter membrane fatty acid and 
phospholipid profiles causing changes in membrane permeability, diffusion, fluidity, as well as 
reducing the activity of certain enzymes that affect overall cell function and integrity.9,10,14,15 
Phospholipids distribute assymetrically within the lipid bilayer membrane such that neutral 
zwitterionic phospholipids with large polar head groups align towards the exofacial leaflet while 
neutral or acidic phospholipids with small polar head groups orient towards the cytofacial 
leaflet (Table 1). Such phospholipid distribution prompts cytofacial leaflet to be more negatively 
3 
 
charged than the exofacial leaflet establishing a charge gradient across the phospholipid 
membrane. The movement of phospholipids within the plane of the membrane is easily 
attainable and it does not disrupt the charge gradient. Conversely, the transbilayer migration 
that entails the movement of lipids from exofacial leaflet to cytofacial leaflet or vice versa is 
relatively intricate as it requires the passage of lipids through the hydrophobic bilayer core 
which has high activation energy associated with it.14 Ethanol has been shown to increase the 
rate of transbilayer migration in the synaptosome that interferes with the electrophysiology of 
the plasma membrane as well as intracellular signaling caused by the release of cytofacially 
bound divalent metal counterions.9,14 ALDH can diminish the teratogenic effects of 
acetaldehyde by reducing acetaldehyde to acetate which ultimately gets converted to carbon 
dioxide and water via the Krebs cycle.16 
 
Table 1: Phospholipid selectivity in lipid bilayers.  
 
Leaflet Lipid Enriched Charge 
 Phosphatidylcholine Zwitterionic 
Exofacial Sphingomyelin Zwitterionic 
 Glycolipids Neutral or anionic 
 Phosphatidylserine Anionic 
Cytofacial 
Phosphatidylinositol Anionic 
Phosphatidylethanolamine Neutral  
 Cholesterol  
 
 
 
Alcohol can also be metabolized via non-oxidative pathways by fatty acid ethyl ester 
(FAEE) synthase and phospholipase D (Figure 1). FAEE synthase esterifies fatty acid in the 
presence of ethanol forming fatty acid ethyl ester while phospholipase D utilizes ethanol as a 
substrate to convert phosphatidylcholine to phosphatidylethanol (PEth) via 
transphosphatidylation reaction. In normal conditions, phospholipase D hydrolysis 
phospholipids leading to the formation of phosphatidic acid; however, in the presence of 
ethanol, ethanol competes with water for phospholipase D resulting in the accumulation of 
phosphatidylethanol that disrupts the surface charge and lipid profile of the membrane 
together with the distortion of electrostatic interactions and hydrogen bonds persisting 
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between the lipids. Ethanol also interferes with phospholipase D mediated signal 
transduction by reducing the production of phosphatidic acid required for optimum cellular 
activity.
17 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Oxidative and non-oxidative metabolic pathways of ethanol. 
 
1.2. Mouse Brain Structure and Function: Coronal Sections 
 
 Brain is one of the most important organs of our body that processes received signals 
and controls our functions such as emotions, intelligence, creativity and memory. Some of the 
critical substructures of the brain are cerebral cortex, corpus callosum, hippocampus, thalamus, 
and hypothalamus whose localization is illustrated in Figure 2. Cerebral cortex includes visual 
cortex, auditory cortex, somatosensory cortex, and motor cortex. Cortex primarily contains 
nerve cell bodies that makes it appear as gray-brown; thereby giving it a name – gray matter. 
The inferior border of the cerebral cortex can be identified in the sagittal view as the superior 
border of the corpus callosum.18 Cerebral cortex is primarily responsible for motor functions, as 
ETHANOL 
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ACETATE 
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Triglyceride Lipase 
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OXIDATIVE PATHWAY NON-OXIDATIVE PATHWAYS 
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well as language, learning, attention and mental imagery.19 Corpus callosum contains large 
number of axons that makes its appearance white; thereby giving it a name – white matter. It is 
located throughout the cerebrum and forms distinct M shaped structure.18 It interconnects the 
two hemispheres and transmits messages from one side of the brain to the same region on the 
other side of the brain.20   
 
Hippocampus is located at the immediate inferior and medial-lateral to the corpus 
callosum. Hippocampus regions belonging to the left and right hemispheres are separated by 
lateral ventricles and are connected via neurons.18 Hippocampus is part of the limbic system 
and is responsible for consolidating information from short term memory to long term 
memory.21 Hypothalamus spans from the midline to interior clefts in both hemispheres and 
primarily controls autonomic system.18 It plays critical roles in controlling behaviors such as 
hunger, thrust and sleep, as well as in maintaining homeostasis such as regulating body 
temperature, blood pressure, emotions and secretion of hormones.22 Thalamus is located 
superior to hypothalamus and is surrounded by third ventricles.18 It relays sensory signals, 
including motor signals, to the cerebral cortex. It plays a role in the regulation of pain sensation, 
consciousness, sleep, attention, alertness, and memory.23  
 
Figure 2: Anatomy of the mouse brain depicting localization of various substructures of the 
brain  
Thalamus 
Cerebral Cortex 
Corpus Callosum 
Hippocampus 
Hypothalamus 
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1.3. Role of phospholipids in neuronal differentiation 
 
Neuronal differentiation is a complex process that initiates with the formation of 
neurites, long cellular projections, from the cell body. These neurites undergo extensive 
changes in length and shape during its elongation stage to reach a specific target.24 Neuronal 
outgrowth dramatically increases cell surface area which is mediated by different types of 
phospholipids involved in membrane biosynthesis. Membranes play critical role in the 
generation and propagation of ionic currents essential for neuronal signal transduction.25 
Among various phospholipids involved in membrane biosynthesis, phosphatidylcholine (PC) 
being the most abundant phospholipid accounts for about 58% of total phospholipids in 
neuronal membranes.26 Furthermore, PC plays critical role in the synthesis of an essential 
neurotransmitter, acetylcholine, which modulates synaptic transmission and excites various 
classes of neurons such as pyramidal cells and dendrite-targeting GABAergic interneurons.27  
The reduction of PC level is associated with memory deficits in dementia and Alzheimer 
diseased states.28,29 In these diseased states, increasing the level of acetylcholine specifically in 
the cortical region have demonstrated enhanced neuron sensitivity to external stimuli and 
increased focused attention to sensory input.30 On the other hand, extensive accumulation of 
PC in the brain is also detrimental and is linked to conditions such as schizophrenia. 
Schizophrenia patients demonstrate higher levels of acetylcholine that causes overstimulation 
of nicotinic and muscarinic receptors at the synapses.30,31 Furthermore, acetylcholinesterase 
knockdown study revealed increased anxiety and depression like symptoms associated with 
excessive acetylcholine accumulation in rodents.32  
 
Phosphatidylserine (PS) is the major anionic phospholipid that accounts for 13-15% of 
phospholipids in the cerebral cortex. PS is predominantly localized in the inner leaflet of the 
plasma membrane; however, it is initially introduced in the exofacial leaflet of the membrane 
and is then migrated to cytofacial leaflet by floppase enzyme with the aid of ATP.33 Excessive 
accumulation of PS in neuronal cells increases its buildup in the outer leaflet causing 
uncontrolled ion fluxes across the membrane that consequently disrupts cellular signalling.34 
Furthermore, the accretion of PS in outer leaflet triggers apoptotic responses in the cell via 
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phagocytosis causing neuronal degeneration.35.36 Within the cytofacial leaflet, PS plays critical 
role in the release of neurotransmitters by exocytosis and modulation of numerous synaptic 
receptors and proteins in neuronal membranes.37 PS facilitates neuronal differentiation and 
survival by activating signaling pathways mediated by various proteins including Akt, protein 
kinase C and Raf-1 that interacts directly with the anionic domain of PS.37 DHA has 
demonstrated to enhance PS production in neuronal membranes; thereby  facilitating PS 
associated signaling mechanisms. However, alcohol have been shown to inhibit DHA induced PS 
production pathway imposing adverse effects on critical signalling mechanisms involved in 
neuronal differentiation.37  
 
Phosphatidylinositol is one of the most reactive phospholipids due to its inositol ring 
constituting multiple free hydroxyl groups.38 These hydroxyl groups can be phosphorylated in a 
combinatorial manner by PI kinases forming astonishing range of inositol phosphates with 
unique functions.39 Phosphorylated head groups of PI mediates recruitment of proteins to the 
membrane which is essential for various cellular pathways including cell proliferation and 
survival, vesicle trafficking, ion channel regulation, and glucose transport.40 Amplified PI levels 
in the brain can increase the abundance of its phosphorylated products that can ultimately 
overstimulate critical cellular pathways causing adverse effects related to brain development. 
Such adverse effects have been recognized in cancer patients where enhanced PI 3-kinase 
activity excessively activates cell proliferation pathways.  PI 3-kinase inhibitors have been 
proposed as promising drug candidates for cancer therapies.41  
 
Sulfatide is the most abundant sulfoglycolipid that is enriched in myelin sheath and 
accounts for about one-third of total myelin lipids.42 Sulfatide (ST) is present in 
oligodendrocytes and Schwann cells in early stages of development and is upregulated before 
the progression of myelination.43 ST is primarily located in the outer leaflet of the membrane 
and constitutes about two-third of the phospholipids present exclusively in the exofacial leaflet. 
ST is responsible for the differentiation of myelinating cells,44 and formation of paranodal 
junction by acting as a negative regulator of oligodendrocyte differentiation such that its 
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deficiency causes increase in the number of differentiated oligodendrocytes in the brain.45,46 ST 
also plays critical role in glial axon signaling by maintaining sodium and potassium ion channel 
clusters.43 The excessive accumulation of ST in neurons can lead to axonal degeneration, 
demyelination and cortical hyperexcitability causing significant impairments in brain 
development.47,48 One of the diseases associated with sulfatide accumulation is metachromatic 
leukodystrophy that has been shown to reduce nerve conduction velocity, increase 
heterogeneity in the thickness of myelin, and upregulate frequency of hypomyelinated and 
demyelinated axons in corpus callosum of afflicted patients.47 Patients suffering from 
Parkinson’s disease also demonstrate elevated levels of ST in superior frontal and cerebellar 
gray matter.49 Furthermore, lethal audiogenic seizures have been shown to result due to 
excessive ST accumulation in mouse neurons.50  
 
1.4. FASD Investigation by Mass Spectrometry: Previous Work 
 
 
Over the last decade, FASD research by mass spectrometry increased immensely and has 
been directed towards the detection of non-oxidative ethanol metabolites, FAEE and PEt, and 
the development of new protein biomarkers for FASD identification. Various MS based methods 
were developed and validated to quantify FAEE in neonatal meconium and hair matrices with 
high accuracy and precision. FAEEs were isolated by headspace solid phase microextraction (HS-
SPME)51 and microwave assisted extraction (MAE)52 methods, which were detected by GC-MS 
or LC-MS techniques53 and quantified using D5-ethyl ester internal standards. The detection 
method of PEt, another ethanol metabolic product, was recently developed by the United 
States Drug Testing Laboratory (USTDL) in dried blood spots that were collected from newborns 
for routine testing and illicit drug testing.54 PEt were isolated by ultrasound assisted dispersive 
liquid-liquid microextraction and detected by LC-MS.55
 
 
The effect of ethanol on placental, embryonic, endothelial and amniotic fluid protein 
expression was also explored during recent years using MS based techniques. Forty-five 
Placental proteins were detected by Q Exactive Hybrid Quadrupole-Orbitrap mass spectrometer 
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that were found to be related to alcohol metabolism. Additionally, specific isoforms of alcohol 
dehydrogenase and aldehyde dehydrogenase were discovered to be altered in response to 
ethanol.56 Similarly, modification in 40 embryonic proteins involved in cellular function, 
ubiquitin proteasome pathway and Myc transcription factor cascades were identified using LC-
MS.57 The endothelial proteome was also investigated using iTRAQ labeling followed by LC-MS 
analysis; fourteen proteins were discerned to be upregulated while 17 proteins were 
downregulated including those responsible for transcription/translation regulation, histones 
and redox balance.58 Lastly, amniotic fluid proteome analysis conducted by matrix assisted laser 
desorption-time of flight (MALDI-TOF) mass spectrometry exhibited significant drop in alpha 
fetoprotein (AFP) levels which can be used as a potential biomarker for the identification of 
FASD.59 To the best of our knowledge, DESI-MS has not been employed to inspect FASD 
phospholipids till date and will thus be the primary goal of this study. 
 
1.5. Ambient Ionization Mass Spectrometry Imaging 
 
Mass spectrometry imaging (MSI) allows chemical and spatial profiling of analytes in a 
wide variety of sample types with complex matrices. Ambient ionization mass spectrometry 
(AMS) imaging is a specific field of MSI that enables the acquisition of sample images in an open 
environment. One of the major benefits associated with AMS methods is that the sample 
requires little or no sample preparation and can be analyzed directly in the native state thereby 
reducing total time of analysis.  Furthermore, pre-treatment of the sample can be accomplished 
concurrently during imaging analysis which cannot be achieved in vacuum based methods. AMS 
has been widely explored in numerous areas of research including forensics, drug development 
and discovery, lipidomics, metabolomics, cancer diagnostics, microbiology, and natural product 
analysis. Cancer and disease diagnostics is predominantly accomplished by histopathology 
analysis that utilizes various staining procedures followed by microscopic analysis. However, 
AMS is rapidly gaining recognition due to its ability to detect multiple biomarkers in a single 
analysis with significantly shorter analysis time in comparison to histopathology tests. Since the 
invention of desorption electrospray ionization, about 40 unique AMS ionization technique have 
been developed, some of which are summarized in Figure 3. 
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Ambient Ionization  
Technique  
Type of 
Ionization 
Ion Source Schematic  Imaging 
Resolutions 
 
 
Desorption 
Electrospray Ionization 
(DESI)  
 
 
Liquid 
extraction 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
100-200 µm 
(35 µm)a 
 
 
Air Flow Assisted 
Desorption 
Electrospray Ionization 
(AFADESI)  
 
 
Liquid 
extraction 
 
 
 
 
 
 
 
 
 
200-300 µm 
(200 µm)a 
 
 
 
 
Easy Ambient Sonic-
Spray Ionization 
(EASI)  
 
 
 
Spray based 
 
 
 
 
 
 
 
 
 
 
100-200 µm 
(50 µm)a 
 
 
Nano Electrospray 
Desorption Ionization 
(nano-DESI)  
 
 
 
Liquid 
Extraction 
 
 
 
 
 
 
 
 
50-100 µm 
(12.5 µm)a 
 
 
Laser Ablation 
Electrospray Ionization  
(LAESI)14/ Laser 
Electrospray Mass 
Spectrometry (LEMS)  
 
 
 
 
Two steps 
(Laser 
ablation and 
Electrospray 
ionization) 
 
  
 
 
200-300 µm 
(30 µm)a/  
60 µm a 
 
 
 
 
N2 
V 
 
 
N2 
N2 
V 
 
 
MS inlet 
MS inlet V 
 
MS inlet 
N
2
 
  V MS inlet 
11 
 
Ambient Ionization  
Technique  
     Type of 
   Ionization 
Ion Source Schematic        Imaging         
Resolutions 
 
 
 
Single Probe  
(SP)  
 
 
 
 
 
 
Liquid 
Extraction 
   
 
 
10-20 µm 
(8.5 µm)a 
 
 
Liquid Microjunction- 
Surface Sampling 
Probe 
(LMJ-SSP)  
 
 
 
 
Liquid 
Extraction 
  
 
 
0.5-1 mm 
(0.5 mm)a 
 
 
Laser Ablation-Liquid 
Capture Surface 
Analysis 
(LA-LCSA)  
 
 
 
 
Liquid 
Extraction 
  
 
 
(50 µm)a 
 
 
Desorption 
Atmospheric Pressure 
Chemical Ionization 
(DAPCI)  
 
 
 
 
 
Plasma 
 
  
 
 
200-500 µm 
(58 µm)a 
 
 
Desorption 
Atmospheric Pressure 
Photoionization  
(DAPPI)  
 
 
 
 
Photo- 
ionization 
  
 
 
1000 µm 
(700 µm)a 
 
 
 
 
 
 V 
  V 
MS inlet N
2 
gas & 
Reagent 
 vapor 
Corona  
Discharge 
MS inlet 
UV 
lamp 
N
2
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Ambient Ionization  
Technique  
Type of 
Ionization 
Ion Source Schematic  Imaging 
Resolutions 
 
 
Laser Ablation Direct 
Analysis in Real Time 
Imaging 
 (LADI)  
 
 
 
 
Two step 
(Laser 
Ablation and 
Plasma 
Ionization) 
  
 
 
50 µma 
 
 
Picosecond Infrared- 
Laser Ablation 
Electrospray Ionization 
(PIR-LAESI)  
 
 
 
 
Two step- 
(Laser 
Ablation and 
electrospray 
ionization) 
  
 
 
100 µma 
 
 
Liquid Extraction 
Surface Analysis 
(LESA)  
 
 
 
 
 
Liquid 
Extraction 
  
 
 
1 mm 
(350 µm)a 
a The highest lateral resolution attained for the ambient mass spectrometry imaging technique 
 
Figure 3: Summary of various ambient ionization techniques with their respective mechanism of 
ionization, schematic of ion source and image resolution. Reproduced from Perez et. al.60  
 
1.5.1. Desorption Electrospray Ionization Mass Spectrometry (DESI-MS) 
 
 
Inspired from various surface analysis techniques such as matrix assisted laser 
desorption ionization (MALDI) and secondary ion mass spectrometry (SIMS), Takats et al. 
introduced desorption electrospray ionization (DESI) in 2004 that has numerous advantages 
over the previous techniques (Figure 4).61 Both MALDI and SIMS require vacuum for efficient 
desorption and ionization while DESI being an ambient ionization technique is capable of 
successfully ionizing surface molecules under atmospheric pressure. Furthermore, unlike MALDI 
that requires intense sample preparation with matrix, DESI can directly analyze thin sample 
sections, sample blotted on the surface, as well as dry samples without additional sample 
PIRL  
system 
MS inlet 
 V 
DART  
MS inlet 
UV 
laser 
N
2
 
  V MS inlet 
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preparation. All these techniques have their respective advantages and disadvantages. MALDI is 
the most versatile method that can analyze samples ranging from small metabolites to large 
biological macromolecules such as proteins; however it requires the largest sample preparation 
time for the analysis. SIMS, on the other hand, has the highest resolution due to its smallest ion 
beam diameter, but it cannot operate at ambient conditions. DESI has the least sample 
preparation time along with the ability to manipulate samples within the experiment being 
conducted under atmospheric conditions, while it has moderate resolution and sample range.62 
 
Figure 4: Conventional mass spectrometry techniques. (a) Matrix assisted laser desorption 
ionization (MALDI) shoots laser on sample embedded in matrix. (b) Desorption electrospray 
ionization (DESI) uses solvent spray to directly analyze samples (c) Secondary ion mass 
spectrometry (SIMS) uses pulsed ion beams to desorb molecules. Comparison of (d) spatial 
resolution (e) mass range capability, and (f) sample preparation requirement of MALDI, DESI 
and SIMS techniques. Adapted from reference.62 
 
DESI setup incorporates four major components: a spray capillary to introduce solvent at 
the surface, outer capillary to introduce nebulizing gas, a moving stage where the sample of 
interest is mounted on a specific surface, and an atmospheric pressure ion transfer line 
connected to the mass spectrometer to collect sample ions for MS analysis (Figure 5). DESI 
utilizes a solvent spray with applied voltage to initiate desorption process by the formation of 
primary charged solvent particles directed to the sample surface with the aid of nebulizing N2 
gas. These charged microdroplets dissolve analyte molecules upon hitting the surface and 
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sputters them via droplet pickup mechanism forming secondary charged particles that are 
directed into MS inlet.63 Analyte charged particles can also be produced by a charge transfer 
mechanism, wherein charge from the solvent particles in gas phase gets transferred to the 
sample molecules on the surface with high momentum to induce sample desorption from the 
surface. There is also a possibility that the sample molecules first get desorbed by the impact of 
charged solvent particles followed by the gas phase charge transfer from solvent to analyte 
molecules. Combination of these ionization mechanisms occur for majority of the analytes with 
one of the mechanism being predominant based on the chemical nature of the analyte, 
composition of the solvent, and physical properties of the surface.64 
 
Figure 5: Schematic of sample ionization by DESI-MS. Solvent is sprayed through the inner spray 
capillary (red) and nebulizing gas through the outer capillary (blue). Solvent hits the surface, 
ionizes molecules, and creates secondary charged droplets that enter into MS inlet.64 
 
To ensure high ionization efficiency of DESI, optimization of certain geometrical 
parameters is extremely critical. These parameters include tip to surface distance, tip to inlet 
distance, incident angle as well as collection angle that typically works best at 2-3mm, 4-8mm, 
55-60°, and 5-10˚ respectively for majority of the analytes (Figure 6a). The selection of an 
appropriate solvent is also essential since the ionization of analyte depends on the ability of 
solvent to dissolve analyte molecules at the sample surface. The utilization of methanol:water 
(1:1) and acetonitrile:water (1:1) solvent systems have been shown to efficiently ionize lipid 
molecules while a mixture of DMF and water have been widely employed to ionize fatty acid 
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moieties. The ionization efficiency of analytes can be further enhanced by the addition of weak 
acids such as acetic acid or formic acid into the solvent. The polarity of analyte can also be 
reversed by the addition of salts such as sodium acetate or formate that form adducts with the 
analyte molecule allowing detection of these molecules in negative ionization mode which 
would otherwise be detected solely in positive ionization mode.61,65
 
 
1.5.2. DESI-MS Imaging 
 
Sample images can be acquired by DESI via programmed software that provides in-depth 
information corresponding to relative quantitation and distribution of various metabolites 
within the sample (Figure 6b). The stage where the sample is mounted has the ability to move 
in x and y directions. The sample is segregated into a large number of pixels determined by 
spatial resolution, and the image is obtained by rastering along the x-direction while acquiring 
mass spectrum for each pixel within that row. The stage is then moved in y-direction 
determined by step size to the next consecutive row where the process is repeated. Once the 
acquisition of mass spectra for the entire sample size is completed, the data set is collated 
together and plotted in two-dimensional space to obtain spatial distribution of ions in the 
sample. A color-coding scheme can be utilized to obtain relative intensity of ions in the sample. 
Typically 150µm spatial resolution is achieved by DESI; however, the resolution can be 
increased up to 40µm under specific operating conditions.65,66 
(a)                 (b) 
  
  
Figure 6: Schematic of (a) DESI geometric parameters with incident angle (α), collection angle 
(β), spray to surface distance (d1), and MS inlet to surface distance (d2). (b) DESI imaging that 
splits sample into multiple rows and acquires spectrum for each pixel within the row.67,68  
 
16 
 
In recent years, DESI-MSI has been widely explored for its applications in clinical 
settings. It has been extensively utilized to investigate metabolite, lipid and fatty acid profiles in 
variety of cancers and other disease affected tissue types such as Parkinson’s and Alzheimer’s 
disease.69 These profiles tend to alter, either in intensity or distribution, in response to disease 
which is targeted as a potential biomarker for disease diagnostics. Tumor tissues have been 
successfully segregated from normal tissues using DESI coupled with multivariate statistical 
analysis such as principal component analysis (PCA).60 Recent advances in DESI have allowed 
accurate identification of tumor margins that are critical for efficient tumor extraction during 
surgical procedure. The increasing number of lipidomic research studies emphasizing the 
apprehension of lipid profiles of diseased state tissues indicate the significance of lipid 
composition for the identification of disease associated biomarkers.65,66 
 
1.6. Statistical Approach: Principal Component Analysis 
 
Principal Component Analysis (PCA) is a multivariate statistical analysis that is most 
widely used to reduce dimensions of the data set. PCA analyzes observations described by 
numerous inter-correlated variables to extract the important information from the data table 
and express it as a set of linearly uncorrelated orthogonal variables called principal 
components. Thus, PCA transforms the data to create a new coordinate system such that the 
total number of variables in the data set equals total number of coordinates. The values of 
these new variables for the observations are called factor scores. The orthogonal 
transformation is defined in such a way that the first principal component has the largest 
possible variance, accounting for as much of the variability in the data as possible, and each 
succeeding component have the highest variance possible while being orthogonal to the 
preceding component. Thus, the first two or three components represent most of the variance 
in the data.70,71 
In this study, PCA was used to disclose the variability between three healthy and three 
FASD brain samples, as well as the gray and white matter of the brains. Score plots and biplots 
were used for data analysis as it provides simple representation of complex multidimensional 
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data set. A score plot represents various samples according to its score on the principal 
component scale such that the points closer together correspond to observations that have 
similar scores with less variability while the points farther apart have most variability. The 
region corresponding to similar scores with less variability can be highlighted by circle or ovals 
with different colors on the principal component axis to indicate unique clusters. The formation 
of distinct clusters in the score plot represents various groups of samples that have less 
variability within the cluster but large variability from the other sample groups.  
On the other hand, biplot is the simultaneous interpretation of both rows (FASD and 
wildtype brain samples) and columns (phospholipid ions) that represent objects as well as 
vectors pointing in the direction that has the highest squared multiple correlation with the 
principal components.72 In our data set, FASD and wildtype brain samples represented points; 
while direction of vector corresponded to the correlation of phospholipid ions with various 
samples. Biplots used for multivariate statistical analysis follows an interpretation rule that the 
correlation of phospholipid ions with sample type is better than average if the angle between 
its vector and sample’s vector is <90°; while the correlation is lower than average if the angle is 
>90°.72 Thus, the phospholipid ions that are more correlated with FASD brains point towards 
the FASD cluster forming an acute angle indicating positive correlation corresponding to higher 
abundance in FASD samples. On the other hand, phospholipid ions that point towards wildtype 
cluster forms an obtuse angle with FASD cluster indicating negative correlation corresponding 
to lower abundance in FASD samples. 
1.7. Research Aims 
 
 
The current study aims at monitoring the impact of alcohol on fetal brain phospholipids 
that plays critical role in numerous cellular pathways vital for appropriate cognitive functions. 
Phospholipids are the primary constituent of membrane bilayers whose disruption can alter 
electrophysiology of the cell. The effect of ethanol on phospholipids has been previously 
investigated by other techniques such as the use of fluorescent dyes and their detection by UV 
absorption.15,73,74 However, alterations in phospholipid composition and distribution in 
response to ethanol has not been previously explored by MS based techniques. It is 
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hypothesized that alcohol increases the overall level of phospholipids in the entire FASD brain 
as well as modulates its abundance in specific regions of the brain that leads to the adverse 
behavioral responses observed in these patients. In this study, the variation in phospholipid 
distribution was investigated by DESI-MSI as the coupling of DESI with MS imaging adds to the 
tremendous advantages of MS by providing an interface for sample imaging that, in addition to 
providing sample identification and characterization, gives insight into the distribution of 
molecules in different regions of the tissue sample. Furthermore, high resolution MS instrument 
was used to characterize phospholipid molecules as it provides sufficient mass accuracy for the 
calculation of exact mass and elemental composition of ion peaks for accurate identification of 
phospholipids in complex tissue types.75  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
19 
 
CHAPTER II 
Experimental 
 
2.1. Mouse Husbandry and Ethanol Treatment 
 
 
This section of the study was done in collaboration with Dr. Peter Carlen at the 
University of Toronto. The University Health Network animal ethics committee in Toronto 
approved this FAS study, and all experimental procedures were performed in accordance to the 
recommendations of the Canadian Council on Animal Care (Protocol 2011-09-GZ). C57/BL6 male 
and female mice were obtained from Charles River Laboratories (Montreal, Quebec, Canada) 
and were subjected to ethanol consumption as described by Kaminen-Ahola et al., 2010. Briefly, 
6-8 week old mice were grouped together in the same cage and were allowed to breed. Mating 
was confirmed by the presence of vaginal plugs in female mice whereupon male mice were 
removed from the cage. Drinking water was replaced with 10% (v/v) ethanol, and was 
voluntarily consumed by the pregnant mice from the day of mating, gestation day (GD) 0.5, to 
GD 7.5 corresponding to the first trimester of gestation in mouse. Control offspring were 
obtained from pregnant mice that were not exposed to alcohol during gestation. All 
experiments were conducted on male and female postnatal offspring aged 30 days that were 
randomly selected from control and prenatal alcohol exposure (PAE) pregnancies. Three control 
and three PAE litters were tested in this study. 
 
2.2. Mouse Brain Sample Preparation and Cryosectioning 
 
Control and PAE mice were anesthetized with an intra-peritoneal injection of 
pentobarbital (50-90 mg/kg body weight) and decapitated by our collaborators at University of 
Toronto. The brain was quickly removed and embedded in a melted solution of 2.5% 
carboxymethylcellulose (CMC) and 5% gelatin placed in an appropriate mold based on tissue 
size. The tissue orientation was adjusted appropriately and air bubbles, if present, were 
removed from the solution. A plastic cassette was placed on top of the mold and the 
embedding solution was allowed to solidify. 
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Coronal sections of the embedded brain were obtained using Shandon Cryotome FE and FSE 
from Thermo Fischer Scientific (Waltham, Massachusetts, USA). The cryostat chamber 
temperature, cryobar temperature and specimen temperature were modulated between -16˚C 
and -20˚C while clearance knife angle was adjusted to 2-3˚ in order to obtain 20µm thin tissue 
slices. The tissue sections were thaw mounted on microscopic glass slides and stored at -80˚C 
until analyzed. Tissue sections were air dried for 20 minutes prior to DESI-MS analysis. 
 
2.3. Phospholipid Extraction and Characterization using HRMS 
 
The method of Bligh and Dyer76 was followed for the extraction of phospholipids from 
brain tissue.
 
The weight of the brain was measured using an analytical balance and the brain 
was transferred into glass dounce homogenizer. 3ml of a mixture of chloroform:methanol (1:2 
v/v) was added per gram of tissue to homogenize the tissue. A small amount of homogenate 
(1ml) was removed and the remaining tissue residue was further homogenized with 1ml of 
chloroform per gram of tissue. The homogenates were combined and briefly centrifuged to 
remove tissue debris. 1ml of chloroform per gram of tissue was added into the mixture followed 
by the same volume of 0.9% NaCl (1ml per gram of tissue). The solution was centrifuged to 
induce phase separation and phospholipids were collected in the lower chloroform phase. The 
chloroform layer was transferred to another tube which was then dried under a nitrogen 
stream and re-suspended in methanol for HRMS analysis. 
 
High mass accuracy analysis and tandem MS of phospholipid extract was obtained using 
LTQ Orbitrap Elite mass spectrometer (Thermo Fischer Scientific, Bermen, Germany). Full scan 
mass spectra were recorded in the mass range of m/z 500-1000 at sample flow rate of 5µL/min. 
The spray voltage was set to 4kV and capillary temperature to 250°C. Tandem MS were 
acquired at the normalized collision energy of 20-25% with mass resolving power of 100,000 
FWHM and isolation window of m/z 0.5-1. 
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2.4. DESI-MS and DESI-MS Imaging 
 
 
DESI-MS was performed using a laboratory built ionization source, similar to the 
commercial source from Prosolia, Inc., coupled to a linear ion trap mass spectrometer (LTQ) 
operated by XCalibur 2.0 software (Thermo Fischer Scientific). Glass slides containing brain 
sections were mounted on the moving stage capable of moving in xyz direction and were 
analyzed in both positive and negative ionization modes over the mass range of m/z 500 to 
1000. Pure methanol was used as the spray solvent and delivered at a flow rate of 5 µL/min. 
The sprayer to surface distance was set at 2 mm, sprayer to MS inlet distance at 5 mm, and 
incident angle at 62˚. The typical source parameters used were automatic gain control (AGC) 
off, 200 ms maximum injection time with 3 microscans, 250˚ capillary temperature, and 100 PSI 
nitrogen gas pressure. 
 
For DESI-MS imaging, brain tissue size was measured and sample scan rate was 
calculated based on the desired image resolution of 150 µm, flow rate of 5 µL/min and scan 
time of 0.82 s. The sample was segregated into multiple rows defined by resolution and the 
tissue was raster scanned at a constant velocity of 183 µm/s. Mass spectra were obtained for all 
the rows and Xcalibur 2.0 mass spectral data set was converted into BioMap compatible format 
using ImageCreator version 3.0 that allowed the processing of spectral data to generate 2D 
spatially resolved ion images. 
 
Statistical analysis, specifically principal component analysis (PCA), was performed on 
the entire brains as well as gray and white matter of FASD and healthy brains using 
metaboanalyst software.77 Region of interest (ROI) was selected in Biomap that provides an 
average mass spectrum corresponding to the designated area. ROI dataset was further 
processed using mMass software in which data was filtered using 5-8% and 25% relative 
intensity threshold and baseline correction was also implemented. Data was normalized to the 
base peak referring to the most intense peak in mass spectrum. 
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CHAPTER III 
Results and Discussion 
 
3.1. Phospholipid Identification by DESI-MS 
 
FASD and control mouse brains were cryosectioned into 20µm thin slices, thaw 
mounted on glass slides and directly analyzed using DESI-MS. The spectrum obtained by DESI-
MS shows multiple molecular ion species in positive ionization mode ranging from m/z 756.5 to 
m/z 872.3 (Figure 5 a, b); while negative ionization mode results in the ion peaks ranging from 
m/z 788.5 to m/z 917.4 (Figure 5 c, d). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Full Scan DESI-MS spectra of (a) control mouse brain tissue in positive ion mode, (b) 
FASD mouse brain tissue in positive ion mode, (c) control mouse brain tissue in negative ion 
mode, (d) FASD mouse brain tissue in negative ion mode. Methanol was used as a spray solvent 
at 5µL/min flow rate. 
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Identical phospholipid ions were observed in control and FASD brain sections in both 
positive and negative ionization modes with the ion at m/z 798 being the most abundant ion 
detected in positive ionization mode and the ion at m/z 834 being the predominant ion in 
negative ionization mode. Although FASD brain illustrated similar phospholipids as that of the 
healthy brain, the relative abundance of these phospholipids varied significantly (Figure 7). 
Furthermore, the relative abundance of these phospholipids was also observed to alter with 
respect to the position within the brain section being analyzed by DESI. Thus, multiple spectra 
for the entire brain section were collected and the information was integrated prior to the 
multivariate statistical analysis. The phospholipid intensities in large number of mass spectra 
collected throughout the section were mapped together to obtain 2D ion images depicting 
localization of these phospholipids within the brain section. 
The impact of alcohol on gray and white matter of FASD brain samples was investigated 
in both positive and negative ionization mode. These two regions of interest display unique 
spectral features with distinct phospholipid distribution in healthy brain which was compared 
with its distribution in FASD brain to explore the variations caused by alcohol. In positive 
ionization mode, both FASD and wildtype brain samples showed higher signal intensity for ion 
at m/z 782 in gray matter of the brain. In contrast, the most predominant ion detected in white 
matter of the brain corresponded to the ion at m/z 798 in positive ion mode (Figure 8).  
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Figure 8: Full Scan DESI-MS spectra in positive ionization mode. (a) MS spectrum corresponding 
to gray matter of healthy brain. (b) MS spectrum corresponding to white matter of healthy 
brain. (c) MS spectrum acquired in gray matter of FASD brain. (d) MS spectrum acquired in 
white matter of FASD brain. Methanol was used as a spray solvent at 5µL/min flow rate. 
  
Negative ionization mode also illustrated similar phospholipid ions in respective regions 
of interest in FASD and wildtype brains. The ion at m/z 834 was detected to be the most 
abundant ion in gray matter of the brain; while, the signal intensity of ion at m/z 788 was most 
abundant in white matter of the brain (Figure 9). The signal intensity of other phospholipids 
with respect to the base peak varied remarkably among FASD and healthy brains. The extent of 
variation in phospholipid intensity as well as its distribution could not be directly elucidated 
from DESI-MS spectrum. As a result, principal component analysis (PCA), a powerful statistical 
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tool, was performed on the entire brain as well as gray and white matter of FASD and healthy 
brains to determine the magnitude of variation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Full Scan DESI-MS spectra in negative ionization mode. (a) MS spectrum acquired in 
gray matter of healthy brain. (b) MS spectrum acquired in white matter of healthy brain. (c) MS 
spectrum corresponding to gray matter of FASD brain. (d) MS spectrum corresponding to white 
matter of FASD brain. Methanol was used as a spray solvent at 5µL/min flow rate. 
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3.2. Phospholipid Characterization by HRMS 
 
 
Prior to the imaging and statistical analysis of phospholipid ion molecules, the ions 
were characterized using electrospray ionization (ESI) coupled to high resolution mass 
spectrometry. Lipid extract analyzed by ESI-HRMS resulted in the detection of additional 
molecules which were not previously observed by DESI (Figure 10 a,b). Furthermore, the 
relative abundance of phospholipids observed in DESI and ESI spectra varied significantly. Such 
spectral differences originated from the unique ionization processes associated with the 
techniques. DESI, being surface analysis technique, ionized molecules primarily at the surface 
of the sample while lipid extract obtained from the whole brain tissue comprised of all the 
lipids existing within the tissue which was detected by ESI. 
 
 
 
 
 
 
 
 
 
 
Figure 10: Full Scan MS spectra of (a) mouse brain tissue section acquired by DESI-MS and (b) 
mouse brain lipid extract acquired by ESI-HRMS. 
 
The molecular ion peaks observed in DESI were selected for further fragmentation in 
ESI. The fragmentation of ion at m/z 756.5 resulted in the loss of 59 Da corresponding to the 
characteristic loss of phosphatidylcholine head group, [N(CH3)3], at m/z 697.5 (Figure 11). 
Neutral loss of 16 carbon alkyl chain [C15H31COOH] at m/z 500.3 and sodium ion at m/z 551.5 
was also detected; thereby characterizing the molecule as sodium adduct of 
phosphatidylcholine [PC(16:0/16:0) + Na]
+
 with mass error of 1.3 ppm. 
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Figure 11: ESI MS/MS spectra of phosphatidylcholine [PC(16:0/16:0) + Na]
+
 at m/z 756.5504 
with its fragment ions (1) [PC116:0/16:0) + Na - N(CH3)3]
+
 at m/z 697.4755; (2) [PC(16:0/16:0) + 
Na - C5H14NPO4]
+
 at m/z 573.4837; (3) [PC(16:0/16:0) - Na - C5H14NPO4]
+
 at m/z 551.5029; (4) 
[PC(16:0/16:0) + Na - C15H31COOH]
+
 at m/z 500.3104; (5) [PC(16:0/16:0) + Na - C15H31COOH - 
N(CH3)3]
+
 at m/z 441.2371. 
 
 
Table 2: Phospholipid ion characterization in positive ionization mode using ESI-HRMS.  
 
Characteristic Ions (m/z) Ion Identification ESI Fragment Ions (m/z) 
756.5502 [PC(16:0/16:0)+Na]
+ 
697, 573, 551, 500, 441 
772.5214 [PC(16:0/16:0)+K]
+ 
713, 589, 567, 551 
772.5214 [PE(P-16:0/22:6)+Na]
+ 
729, 631, 609, 488, 463, 305 
782.5624 [PC(16:0/18:1)+Na]
+ 
723, 599, 577, 467, 441 
798.5390 [PC(16:0/18:1)+K]
+ 
739, 615, 441 
798.5390 [PE(P-18:0/22:6)+Na]
+ 
755, 657, 487 
826.5725 [PC(18:0/18:1)+K]
+ 
767, 643, 605 
 
 
The molecular ion peak at m/z 772.5 was also subjected to fragmentation and was 
identified as a mixture of phosphatidylcholine [PC(16:0/16:0)+K]+ and 
phosphatidylethanolamine [PE(P-16:0/22:6)+Na]+ species (Figure 12). Neutral loss of 59 Da 
specific to PC phosphate head group was seen at m/z 713.4 identifying it as [PC(16:0/16:0)+K]+ 
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with a mass error of 2.1 ppm (Figure 12b). On the other hand, phosphatidylethanolamine 
fragmentation lead to the characteristic loss of 43 Da also associated with its head group 
followed by the loss of 16 and 22 carbon alkyl chains at m/z 488.2 and m/z 305.3 respectively 
(Figure 12c). Neutral loss of sodium was also detected and the phospholipid molecule was 
identified as [PE(P-16:0/22:6)+Na]+ with a mass error of 4.5 ppm. The identification of all other 
phospholipids is summarized in Table 2. Similar characterization was also performed in negative 
ionization mode using ESI coupled to LTQ-XL mass spectrometer as shown in Table 3. Among 
the five major ions identified by DESI, three of the ions corresponded to phosphatidylserine 
linked with unique fatty acid chains; while, the other two ions were characterized as 
phosphatidylinositol and sulfatide. 
 
Table 3: Phospholipid ion characterization in negative ionization mode 
using ESI coupled to LTQ-XL mass spectrometer. 
 
 
Characteristic Ions (m/z) Ion Identification 
788 [PS(18:0/18:1)]
- 
810 [PS(18:0/20:0)]
- 
834 [PS(18:0/22:6)]
- 
885 [PI(18:0/20:4)]
- 
888 [ST(24:1)]
- 
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Figure 12: ESI-HRMS spectra of control brain in positive ionization mode. (a) MS/MS Scan of 
molecule at m/z 772.5. (b) MS3 of ion (1) [PC(16:0/16:0)+K-N(CH3)3]
+ at m/z 713.5 with 
fragment ions (2) [PC(16:0/16:0)+K–C5H14NPO4]
+ at m/z 589, and (3) [PC(16:0/16:0)-K– N(CH3)3]
+ 
at m/z 551. (c) MS3 of ion (1) [PE(P-16:0/22:6)+Na–C2H5N]
+ at m/z 729 with fragment ions (2) 
[PE(P-16:0/22:6)+Na– C2H8NPO4]
+ at m/z 631, (3) [PE(P-16:0/22:6)-Na–C2H8NPO4]
+ at m/z 609, 
(4) [PE(P-16:0/22:6)+Na–C15H32CHO-C2H5N]
+ at m/z 488, (5) [PE(P-16:0/22:6)-Na–C15H32CHO-
C2H5N]
+ at m/z 463, and (6) [PE(P-16:0/22:6)+Na–C21H29COOH-C2H8NPO4]
+ at m/z 305. 
 
3.3. DESI-MS Imaging 
 
DESI-MS images of FASD and control brain sections were acquired in both positive and 
negative ionization modes. The images were normalized to the base peak corresponding to the 
ion at m/z 798 in positive ion mode and the ion at m/z 834 in negative ion mode to account for 
signal intensity variations that were not associated with the biological tissue and solely arise 
from image acquisition. The distribution of phospholipids in 30 day old wildtype and FASD mice 
brains in positive ionization mode is illustrated in Figure 13 (a,b). The image at m/z 756 
corresponding to sodium adduct of PC (16:0/16:0) was localized in the cortical region; while a 
mixture of potassium adduct of PC (16:0/16:0) and sodium adduct of PE (P-16:0/22:6) 
collectively ionized at m/z 772 was primarily dispersed in cortical region, hippocampus and 
thalamic regions corresponding to the gray matter of FASD and control brains. On the other 
hand, homogeneous distribution was encountered throughout the brain except lateral 
ventricles for sodium adduct of PC (16:0/18:1) at m/z 782 and the amalgam of potassium 
adduct of PC (16:0/18:1) and sodium adduct of PE (P-18:0/22:6) at m/z 798. The ion image at 
m/z 826, identified as PC (18:0/18:1), illustrated PC distribution in corpus callosum and fimbria 
of hippocampus associated with the white matter of the brain. Among all the phospholipids 
identified by DESI, PC (18:0/18:1) exhibited lower signal intensity in FASD brain suggesting 
reduced PC levels in the white matter. On the contrary, all other phospholipids had significantly 
greater signal intensity in the FASD brain as compared to the control indicating clear 
modulation of phospholipid concentration in response to the alcohol consumption. 
 
Significant variation in relative phospholipid concentration of wildtype and FASD brains 
was also observed in DESI-MS images acquired in negative ionization mode (Figure 13 c,d). PS 
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(18:0/18:1) at m/z 789, PS (18:0/20:0) at m/z 811 and ST (24:1) at m/z 889 were predominantly 
dispersed in corpus callosum and fimbria of hippocampus corresponding to the white matter of 
the brain. While PS (18:0/22:6) and PI (18:0/20:4) at m/z 835 and m/z 886 respectively were 
distributed throughout FASD and control brains. None of the phospholipids were solely 
localized in the gray matter of the brain that would allow direct comparative analysis between 
gray and white matter through DESI-MS images. Signal intensity of all the phospholipids was 
greater in FASD brains as compared to the control suggesting higher abundance of PS and ST 
species in the brain. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: DESI-MS images depicting phospholipid distribution in (a) control and (b) FASD brain 
sections of 30 day old mice acquired in positive ionization mode and (c) control and (d) FASD 
brain sections of 30 day old mice acquired in negative ionization mode. Images were collected 
at a resolution of 150 μm. 
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3.3.1. Principal Component Analysis in Positive Ionization Mode 
 
Principal Component Analysis (PCA) was executed on lipid profiles extracted through 
various regions of interest (ROI) corresponding to whole brain, gray matter and white matter in 
both positive and negative ionization mode. Three wildtype and three FASD brains of same age 
were cryosectioned and imaged independently for PCA analysis using Metaboanalyst software 
(https://www.metaboanalyst.ca; updated and maintained by Xia lab at McGill University). The 
ions for analysis were baseline corrected and further processed using mMass software 
(http://www.mmass.org) using two different selection criteria prior to PCA analysis. Both the 
criteria were set at signal to noise ratio (S/N) of 1; while they varied in relative abundance 
threshold ranging from 5% to 8% for the first criterion and 25% for the second criterion. 
Metaboanalyst was used to auto-scale the data set by mean centering the data set followed by 
dividing the data set by standard deviation of each variable.78 The data set was also normalized 
to the base peak that was unique in regions of interest associated with whole brain, gray 
matter and white matter of the brain. 
 
The entire brain PCA analysis in positive ion mode were assessed by both low and high 
relative abundance threshold criteria employed in mMass. The lower threshold data processing 
resulted in approximately 14 to 17 common ions in 6 samples that included 5 major ions 
detected in DESI-MS images along with other phospholipids prevailing in lower abundance. The 
PCA analysis computed subsequent to data set normalization by signal intensity of base peak 
(the ion at m/z 799) could not separate FASD and wildtype samples in score plot due to the 
contribution of low intensity phospholipids that did not vary significantly among FASD and 
control brains (Figure 14). On the other hand, 25% intensity threshold only resulted in 5 major 
ions of interest and its associated score plot obtained through PCA analysis illustrated adequate 
separation among FASD and control brains (Figure 15a). Consequently, 25% threshold was used 
for further data analysis.  
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Figure 14: Principal Component Analysis score plot of FASD samples in positive ionization mode. 
Six mice samples including three wildtype (highlighted in green) and three FASD brain tissues 
(highlighted in pink) were subjected to PCA analysis. Principal component 1 and 2 (PC 1 and PC 
2) corresponding to 44.7% and 22.9% variability in the data set were plotted on x and y axis 
respectively. The dataset was normalized to the base peak at m/z 798. PCA analysis was 
executed on 16 ions corresponding to entire brain ROI using 5% to 8% relative intensity 
threshold selection criteria. 
 
Biplot obtained from the PCA analysis of whole FASD and wildtype brain showed that 
the vector of ions corresponding to m/z 826 and m/z 782 formed acute angle with wildtype 
cluster while obtuse angle with FASD cluster (Figure 15b). Since the interpretation rule of biplot 
suggests that the phospholipid ions are more correlated if their vectors form acute angle with 
the sample score, it indicates that these phospholipid ions are more abundant in the wildtype 
brain. Similarly, the vector of ions at m/z 756 and m/z 772 formed acute angle with FASD 
cluster while obtuse angle with wildtype cluster indicating that these phospholipid ions have 
higher than average correlation with FASD as opposed to wildtype. Thus, the abundance of 
these phospholipids was demonstrated to be higher in FASD brain in comparison to the control. 
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These results correlate well with DESI-MS images that depict higher signal intensity of ions at 
m/z 756 and 772 in FASD brain illustrated by red color.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15: Principal Component Analysis of FASD samples in positive ionization mode. PCA 
analysis was computed using entire brain area selected as the region of interest. Six mice 
samples comprising three wildtype (green) and three FASD (pink) brain tissues were subjected 
to PCA analysis. Principal component 1 and 2 (PC1 and PC2) corresponding to 58.1% and 35.8% 
variability in the data set were plotted on x-axis and y-axis respectively. The dataset was 
normalized to the base peak at m/z 798. (a) PCA score plot with wildtype (WT) and FASD 
objects representing average mass spectrum obtained from whole brain ROI of each sample. (b) 
PCA biplot indicates contribution of various phospholipid ions in the separation of FASD and 
wildtype tissue samples. The ions at m/z 782 and m/z 826 formed acute angle with wildtype 
cluster and were consequently more abundant in wildtype brains. While, the ions at m/z 756 
and m/z 772 formed acute angle with the FASD cluster and were consequently more abundant 
in FASD brains.  
 
PCA analysis was also conducted on gray and white matter to explore the effect of 
alcohol on the distribution of phospholipids within the brain. PCA analysis could clearly 
distinguish gray and white matter in both wildtype and FASD tissues; while the distribution of 
phosphatidylcholine species was unique in both the brains (Figure 16, 17). 
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Figure 16: Principal Component Analysis of FASD samples in positive ionization mode. PCA 
analysis was conducted on gray (pink) and white matter (green) ROI. Principal component 1 and 
2 (PC1 and PC2) corresponding to 94.6% and 4.7% variability in the data set were plotted on x-
axis and y-axis respectively. The dataset was normalized to the base peak at m/z 782. (a) PCA 
score plot include objects depicting average mass spectrum obtained from respective ROI of 
each sample. (b) PCA biplot indicates contribution of various phospholipid ions in the 
separation of gray and white matter of FASD tissue samples. The ion at m/z 756 formed acute 
angle with the cluster of gray matter and was consequently more abundant in the gray matter 
as opposed to the white matter of FASD brains. All other ions formed acute angle with the 
cluster of white matter and were consequently more abundant in the white matter of FASD 
brains.  
 
Sodium adduct of PC (16:0/16:0) at m/z 756 was more abundant in the gray matter of 
both FASD (Figure 16b) and healthy brains (Figure 17b) in comparison to their respective white 
matters indicating that the distribution of this phospholipid was not impacted by alcohol. 
However, PCA analysis of gray matter in both FASD and wildtype brains indicated higher 
abundance of ion at m/z 756 in FASD brains as opposed to wildtype (Figure 18b). A similar 
trend was observed in the PCA analysis of white matter in FASD and wildtype brains (Figure 
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19b) suggesting that PC(16:0/16:0) is more abundant in FASD brain in comparison to the 
control.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17: Principal Component Analysis of wildtype samples in positive ionization mode. PCA 
analysis was performed on region of interest corresponding to gray (pink) and white (green) 
matter of healthy brain. Principal component 1 and 2 (PC1 and PC2) corresponding to 87.1% 
and 8.7% variability in the data set were plotted on x-axis and y-axis respectively. The dataset 
was normalized to the base peak at m/z 798. (a) PCA score plot include points representing 
average mass spectrum of each sample obtained from its respective ROI. (b) PCA biplot shows 
contribution of various phospholipid ions in the separation of gray and white matter of healthy 
mouse brain samples. The ion at m/z 826 formed acute angle with the cluster of white matter 
and was consequently more abundant in the white matter as opposed to the gray matter of 
healthy brains. All other ions formed acute angle with the cluster of gray matter and were 
consequently more abundant in the gray matter of healthy brains.  
 
The ion at m/z 772 corresponding to potassium adduct of PC(16:0/16:0) and sodium 
adduct of PE(P-16:0/22:6)  was more abundant in the entire FASD brain in comparison to 
healthy brain (Figure 15b). Distribution of these phospholipids varied among both the brains 
such that the signal intensity of these phospholipids was greater in white matter of FASD brain 
in comparison to its gray matter (Figure 16b); while, in the case of healthy brain, their signal 
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intensity was greater in the gray matter as opposed to the white matter (Figure 17b). These 
results were further validated by PCA analysis of FASD and wildtype gray matter that illustrated 
higher abundance in the healthy brain as opposed to FASD (Figure 18b). In contrast, PCA 
analysis of FASD and control white matter indicated higher abundance in the FASD brain (Figure 
19b). These results indicate that alcohol not only increases the overall relative abundance of 
phosphatidylcholine and phosphatidylethanolamine, but also enhances its distribution in white 
matter of the brain. 
 
 
 
 
 
 
 
 
 
 
Figure 18: Principal Component Analysis of gray matter ROI in FASD (pink) and healthy (green) 
tissue samples in positive ionization mode. Principal component 1 and 2 (PC1 and PC2) 
corresponding to 73.8% and 20.7% variability in the data set were plotted on x-axis and y-axis 
respectively. The dataset was normalized to the base peak at m/z 782. (a) PCA score plot exhibit 
objects associated with average mass spectrum obtained from respective ROI of each sample. 
(b) PCA biplot shows contribution of different phospholipid ions in the gray matter of FASD and 
healthy mouse brain samples. The ion at m/z 756 formed acute angle with FASD cluster and 
was consequently more abundant in gray matter of FASD brains. All other ions formed acute 
angle with the wildtype cluster and were consequently more abundant in the gray matter of 
healthy brains.  
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PCA analysis of entire FASD and control brains demonstrated higher abundance of 
sodium adduct of PC(16:0/18:1) at m/z 782 in FASD brain as opposed to the control (Figure 
15b). Furthermore, the signal intensity of this ion was higher in the gray matter of healthy brain 
in comparison to its white matter (Figure 17b).  On the other hand, its relative abundance was 
100% in FASD brain due to which it was used to normalize the data set. Consequently, it could 
not be used to compare FASD gray and white matter (Figure 16 a,b) as well as to compare the 
gray matter of FASD and healthy brains (Figure 18 a,b) indicating that it is predominantly 
distributed in the gray matter of FASD brain. PCA analysis of white matter of FASD and wildtype 
brains indicated higher abundance in FASD brain as opposed to healthy (Figure 19b). 
Consequently, these results demonstrate that alcohol does not impact the distribution of PC 
(16:0/18:1) but solely increases its abundance in FASD mouse models.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: Principal Component Analysis of ROI corresponding to white matter of FASD (pink) 
and healthy (green) brain samples in positive ionization mode. Principal component 1 and 2 
(PC1 and PC2) corresponding to 51% and 40.6% variability in the data set were plotted on x-axis 
and y-axis respectively. The dataset was normalized to the base peak at m/z 798. (a) PCA score 
plot include objects representing average mass spectrum obtained from white matter ROI of 
each sample. (b) PCA biplot indicating the formation of acute angle of all ions with FASD cluster.  
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The signal intensity of ion at m/z 798 corresponding to potassium adduct of 
PC(16:0/18:1) and sodium adduct of PE(P-18:0/22:6) was maximum in both FASD and healthy 
brains; as a result, it was used to normalize the data set for PCA analysis of whole brains (Figure 
15 a,b), gray and white matter of healthy brain (Figure 17 a,b), and white matter of healthy and 
FASD brain (Figure 19 a,b). PCA analysis of gray and white matter of FASD brain illustrated 
higher abundance in white matter (Figure 16b); while PCA analysis of healthy and FASD gray 
matter suggested higher abundance in wildtype as opposed to FASD (Figure 18b). These results 
indicate that phosphatidylcholine and phosphatidyethanolamine are more abundant in 
wildtype than FASD brain and are relatively higher in white matter of the brain as compared to 
the gray matter. Majority of the phosphatidylcholine species demonstrated significantly higher 
level in FASD afflicted mice. The Enhanced level of phosphatidylcholine and acetylcholine has 
been linked with depression and anxiety like symptoms in other diseases which are also 
detected in FASD patients.26   
 
The PCA analysis of potassium adduct of PC(18:0/18:1) at m/z 826 illustrated higher 
abundance in the entire healthy brain as opposed to FASD (Figure 15b). Furthermore, this ion 
was predominantly distributed in the white matter of both wildtype and FASD brains (Figure 
16b, 17b). The PCA analysis of healthy and FASD gray matter indicated higher abundance in 
healthy brain (Figure 18b). However, PCA analysis of healthy and FASD white matter 
demonstrated higher abundance in FASD brain as compared to healthy (Figure 18b). Thus, 
alcohol reduces the overall abundance of PC(18:0/18:1) in the brain and imposes relatively 
greater impact on the gray matter than the white matter of the brain. Lower abundance of PC 
(18:0/18:1) might be associated with its lower turnover rate in white matter in comparison to 
other phosphatidylcholine species localized in gray matter of the brain.79   
3.3.2 Principal Component Analysis in Negative Ionization Mode 
 
A similar trend was observed for PCA analysis performed in the negative ionization 
mode with selection criteria of 5-8% and 25% relative intensity threshold that was normalized 
to the base peak at m/z 834. Lower threshold criterion contributing to the large number of 
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phospholipids could not separate FASD and wildtype samples in PCA score plot; while higher 
threshold criterion associated with 5 major ions of interest successfully separated the two 
sample sets (Figure 20a). PCA analysis was conducted on the entire FASD and healthy brains 
(Figure 20 a,b); gray and white matter of wildtype brain (Figure 21 a,b); gray and white matter 
of FASD brain (Figure 22 a,b); gray matter of FASD and wildtype brain (Figure 23 a,b); and white 
matter of FASD and wildtype brain (Figure 24 a,b).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20: Principal Component Analysis of FASD samples in negative ionization mode. Six mice 
samples comprising three wildtype (green) and three FASD (pink) brain tissues were subjected 
to PCA analysis. PCA analysis was computed using entire brain area selected as the region of 
interest. Principal component 1 and 2 (PC1 and PC2) corresponding to 87.2% and 9.6% 
variability in the data set were plotted on x-axis and y-axis respectively. The dataset was 
normalized to the base peak at m/z 834. (a) PCA score plot shows wildtype and FASD objects 
corresponding to the average mass spectrum obtained from whole brain ROI of each sample. 
(b) PCA biplot indicates contribution of 5 major phospholipid ions in the separation of FASD and 
wildtype tissue samples. All the ions formed acute angle with FASD cluster and were 
consequently more abundant in the entire FASD brain in comparison to the healthy brain.  
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Figure 21: Principal Component Analysis of wildtype samples in negative ionization mode. PCA 
analysis was performed on region of interest corresponding to gray (pink) and white (green) 
matter of healthy brain. Principal component 1 and 2 (PC1 and PC2) corresponding to 98.2% 
and 2.4% variability in the data set were plotted on x-axis and y-axis respectively. The dataset 
was normalized to the base peak at m/z 834. (a) PCA score plot include points representing 
average mass spectrum of each sample obtained from its respective ROI. (b) PCA biplot shows 
contribution of different phospholipid ions in the separation of gray and white matter of 
healthy mouse brain samples. All the ions formed acute angle with the cluster of white matter 
and were consequently more abundant in the white matter of healthy brains.  
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Figure 22: Principal Component Analysis of FASD samples in negative ionization mode. PCA 
analysis was conducted on gray (pink) and white (green) matter ROI. Principal component 1 and 
2 (PC1 and PC2) corresponding to 96.9% and 2.7% variability in the data set were plotted on x-
axis and y-axis respectively. The dataset was normalized to the base peak at m/z 834. (a) PCA 
score plot include objects depicting average mass spectrum obtained from respective ROI of 
each sample. (b) PCA biplot indicates contribution of various phospholipid ions in the 
separation of gray and white matter of FASD tissue samples. All the ions formed acute angle 
with the cluster of white matter and were consequently more abundant in the white matter of 
FASD brains.  
 
 
PS(18:0/18:0), PS(18:0/20:0), and PS(18:0/22:6) were more abundant in entire FASD 
brain (Figure 13d) as well as in the gray and white matter of FASD brain as opposed to healthy 
brain as illustrated in Figure 23b, and 24b. The PCA analysis of gray and white matter of FASD 
brain; and gray and white matter of healthy brain showed greater profusion of PS in the white 
matter of both FASD and healthy subjects suggesting that PS is primarily localized in the white 
matter of the brain. These results indicate that alcohol increases the abundance of PS in FASD 
mouse models but does not impact its localization within the brain. Higher abundance of PS has 
been linked with neurodegeneration in various diseased states which might be the case in FASD 
mouse models as well.36    
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Figure 23: Principal Component Analysis of ROI corresponding to gray matter of FASD (pink) and 
healthy (green) tissue samples in negative ionization mode. Principal component 1 and 2 (PC1 
and PC2) corresponding to 95.3% and 2.9% variability in the data set were plotted on x-axis and 
y-axis respectively. The dataset was normalized to the base peak at m/z 834. (a) PCA score plot 
exhibit objects associated with average mass spectrum obtained from respective ROI of each 
sample. (b) PCA biplot shows contribution of different phospholipid ions in the gray matter of 
FASD and healthy mouse brain samples. All the ions formed acute angle with the FASD cluster 
and were consequently more abundant in the gray matter of FASD brains.  
 
The PCA analysis of PI(18:0/20:4) at m/z 885 showed a similar trend as PS with higher 
abundance in the entire FASD brain as well as FASD gray and white matter in comparison to 
entire healthy brain, and gray and white matter of health brain respectively (Figure 20b, 23b, 
24b). Furthermore, biplot of wildtype gray and white matter indicated higher intensity of PI in 
white matter of the brain (Figure 21b). Similarly, biplot of FASD gray and white matter 
illustrated higher intensity of PI in white matter of FASD brain (Figure 22b). These results 
demonstrate that alcohol exclusively enhances the relative abundance of PI(18:0/20:4) in FASD 
brain without imposing any impact on its distribution within the brain. Higher concentration of 
phosphatidylinositol might be detrimental for the brain development as it can overstimulate 
large number of cellular pathways mediated by PI and its phosphorylated products causing 
adverse effects related to brain development in FASD patients.39 
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Figure 24: Principal Component Analysis of ROI corresponding to white matter of FASD (pink) 
and healthy (green) brain samples in negative ionization mode. Principal component 1 and 2 
(PC1 and PC2) corresponding to 87.9% and 9.6% variability in the data set were plotted on x-
axis and y-axis respectively. The dataset was normalized to the base peak at m/z 788. (a) PCA 
score plot include objects representing average mass spectrum obtained from white matter ROI 
of each sample. (b) PCA biplot shows contribution of various phospholipid ions in the white 
matter of FASD and wildtype samples. All the ions formed acute angle with the FASD cluster 
and were consequently more abundant in the white matter of FASD brains.  
 
The signal intensity of ion at m/z 888 corresponding to ST(24:1) was higher in the entire 
FASD brain as compared to healthy brain (Figure 20b). Its abundance was also higher in the 
gray and white matter of FASD brain in comparison to the gray and white matter of healthy 
brain (Figure 23, 24). Furthermore, PCA analysis of gray matter and white matter in healthy 
brain indicated higher relative intensity of ST in the white matter (Figure 21b). A similar trend 
was observed in the PCA analysis of gray and white matter of FASD brain with higher 
abundance in white matter as opposed to the gray matter of the brain (Figure 22b). These 
results demonstrate that alcohol increases the accumulation of ST(24:1) in FASD brain and 
primarily localizes sulfatide in white matter of the brain. Higher sulfatide levels have been 
associated with demyelination that might also lead to impairments in brain development of 
FASD subjects.47 
 
PCA analysis served as an essential tool to validate the results acquired in DESI-MS 
images and to explore the extent of variability in phospholipid ion intensities of wildtype and 
FASD samples. PCA analysis demonstrated distinct clusters of gray and white matter in wildtype 
and FASD brain indicating that all regions of the brain were highly impacted by alcohol 
administration in FASD mouse models. The phospholipid profile was not only different for 
various regions within the FASD brain but it was considerably different from the gray and white 
matter of wildtype brain as well. DESI-MS images and PCA biplot demonstrated enhanced level 
of PC(16:0/16:0) and PC (16:0/18:1) in both gray and white matter of the brain in response to 
alcohol. While, the level of PE(P-16:0/22:6), PS(18:0/18:1), PS(18:0/20:0) and ST(24:1) 
increased specifically in the white matter of FASD brain as illustrated by both DESI-MS images 
and PCA biplot. DESI-MS images represented homogenous distribution of PC(16:0/18:1), PE(P-
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18:0/22:6), PS(18:0/22:6) and PI(18:0/20:4) in the brain; while it could not demonstrate the 
impact of alcohol on the level of these phospholipids. On the other hand, biplot of PCA analysis 
revealed that these phospholipids were relatively more abundant in the white matter of the 
brain instead of being homogeneously distributed throughout the brain. Furthermore, 
consumption of alcohol was shown to reduce the level of PC(16:0/18:1) and PE(P-18:0/22:6); 
while enhance the level of PS(18:0/22:6) and PI(18:0/20:4) in the brain.  Lastly, PCA biplot and 
DESI-MS images illustrated reduced level of PC(18:0/18:1) in response to alcohol consumption 
in FASD brain samples. All these phospholipids play distinct roles in neuronal differentiation 
and survival. Variations in phospholipid levels can drastically hinder cell proliferation, trigger 
transmigration of lipids within the bilayer, disrupt neuronal signal transmission, alter 
neurotransmitter levels, induce apoptotic effects and initiate neuronal degeneration in the 
brain. These destructive effects are significantly more pronounced in developing brain 
undergoing extensive neuronal differentiation as in the case of FASD in comparison to a well-
developed brain of an adult.   
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CHAPTER IV 
Conclusion and Future Work 
 
Mass spectrometry has been widely used to investigate oxidative and non-oxidative 
alcohol metabolic products and alterations of embryonic proteins in FASD subjects. This work 
highlights the application of ambient mass spectrometry imaging, specifically DESI-MSI, in 
evaluating the impact of alcohol on phospholipids of developing fetal brain. DESI-MS images 
depicted a distinct variation in the relative abundance of phospholipids and their distribution in 
various regions of the brain. Multiple replicates were conducted to validate the results and 
perform principal component analysis that served as a powerful tool for multivariate statistical 
analysis. PCA revealed significantly greater information regarding phospholipid distribution as 
opposed to information perceived from direct visualization of DESI-MS images. Remarkable 
disparity was detected in ten different phospholipids among which majority of the 
phospholipids demonstrated higher relative abundance in FASD brain. Furthermore, distinct 
distribution of phospholipids were detected in gray and white matter such that PC(18:0/18:1), 
PS(18:0/18:1), PS(18:0/22:6), and ST(24:1) were predominantly located in the white matter of 
the brain while all other phospholipids were either dispersed throughout the brain or 
distributed primarily in the gray matter of the brain. DESI-MS integrated with statistical analysis 
demonstrates great potential for forensic studies on human patients suffering from FASD 
disease due to its ability of substantially differentiating normal and FASD tissue samples. 
 
This work serves as an essential preliminary study that lays a strong foundation for 
understanding biological relevance and impact of phospholipid variation on cell proliferation 
and signalling pathways in developing fetal brain. However, it primarily focused on 10 
phospholipids that were detected by DESI and could not explore the entire range of 
phospholipids in a lipidomic study of the fetal brain. Furthermore, it was limited to relative 
quantification of phospholipids in various regions of the brain instead of absolute quantification 
which can reveal significantly greater information regarding the alteration in the abundance of 
these phospholipids in response to alcohol.  Consequently, the research can be extended to 
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further investigate these phospholipids using LC-MS based methods as lipid extraction from the 
entire fetal brain followed by separation of these phospholipids by liquid chromatography 
would allow the detection of large number of phospholipids there were not previously detected 
by DESI. Furthermore, addition of labeled internal standards in the lipid extract would allow 
absolute quantification of these phospholipids which would be of great interest for 
understanding biological mechanisms behind the variation of phospholipid abundance in 
patients suffering from fetal alcohol spectrum disorder. 
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